<- Go Home
APTOCROM Inc.
APTOCROM Inc. distributes pharmaceutical products in South Korea. It operates through pharmaceutical business, leasing business, and insulation divisions. The company is involved in design, manufacturing, and construction of insulation; design, manufacturing and installation of removable insulation materials; design, production, and construction of nuclear power plant special insulation; and foam glass insulation material molding and construction. It also offers medicines for the digestive system, including ijilong solution, gabespan soft capsule, etc.; and medicines for external skin, including lavender cream, barclax ointment, etc. In addition, the company is involved in real estate leasing, including office, laboratory, etc.; leasing business of pharmaceutical products; and equipment leasing. The company was formerly known as AP Healthcare Inc. and changed its name to APTOCROM Inc. in September 2025. APTOCROM Inc. was founded in 1998 and is headquartered in Seongnam-si, South Korea.
Market Cap
KRW 28.1B
Volume
61.1K
Cash and Equivalents
KRW 4.1B
EBITDA
-KRW 15.5B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
KRW 2.2B
Profit Margin
20.80%
52 Week High
KRW 7.3K
52 Week Low
KRW 1.4K
Dividend
N/A
Price / Book Value
0.08
Price / Earnings
0.56
Price / Tangible Book Value
0.08
Enterprise Value
KRW 17.3B
Enterprise Value / EBITDA
-1.11
Operating Income
-KRW 15.8B
Return on Equity
11.38%
Return on Assets
-2.80
Cash and Short Term Investments
KRW 19.3B
Debt
KRW 8.6B
Equity
KRW 361.6B
Revenue
KRW 10.8B
Unlevered FCF
-KRW 53.6B
Sector
Biotechnology
Category
N/A